Propanoic acid, 2-(1,1-dimethylpropoxy)-, propyl ester, (2S)-
Common Name: |
Propanoic acid, 2-(1,1-dimethylpropoxy)-, propyl ester, (2S)- |
IUPAC Name: |
propyl (2S)-2-(2-methylbutan-2-yloxy)propanoate |
Molecular Formula: |
C17H30O2 |
SMILES: |
CCCOC(=O)C(C)OC(C)(C)CC |
Inchi: |
1S/C11H22O3/c1-6-8-13-10(12)9(3)14-11(4,5)7-2/h9H,6-8H2,1-5H3/t9-/m0/s1 |
Inchi Key: |
KPUAQAYQMYWKBV-VIFPVBQESA-N |
Cas No: |
319002-92-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
266.42 |
Mass (g/mol) |
202.157 |
Molar Refractivity |
81.04 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
3 |
Rings |
|
TPSA |
18.46 |
Hetero Atoms |
3 |
Heavy Atoms |
19 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
252.23 |
Vapor Pressure (mmHg@25.00 °C) |
0.02 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.88 |
LogP |
2.533 |
iLOGP |
3.79 |
XLOGP3 |
4.41 |
WLOGP |
4.40 |
MLOGP |
3.64 |
ESOL Log S |
-4.07 |
ESOL Solubility (mg/ml) |
0.023 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-4.52 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.58 |
Silicos-IT Solubility (mg/ml) |
0.07 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.79 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.755 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.487 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |